Resources and Information on Psychedelics and Psychedelic-Assisted Therapy

The Psychedelic Renaissance

Since 2010 or so, there has been a growing recognition in mainstream Western culture that psychedelics have a role as potential tools for personal healing and growth. There has been a steep increase in research studies investigating the use of psychedelics for various mental health issues and psychedelics have enjoyed increased popularity in the media, such as through Michael Pollan’s book “How To Change Your Mind.” In 2020, Oregon passed Measure 109, allowing for the public to access psilocybin treatment by 2023. Because of the rapid pace of news and developments, there is a significant amount of information to keep up with.  We want to share a range of resources below for those who want to learn more about what’s happening in the world of psychedelics.

Places to learn more about the “Psychedelic Renaissance”:


Major Psychedelic Organizations

There are several major organizations involved in psychedelic research that are important to know about. Many others also exist, but these are currently some of the most influential ones as they are the closest to obtaining FDA approval for psychedelic medicine.

  • The Multidisciplinary Association for Psychedelic Studies (MAPS) is a non-profit dedicated to funding psychedelic research and is responsible for the advancements of MDMA-assisted psychotherapy for the treatment of PTSD. Besides being a primary hub of research, they also disseminate resources like books and articles, and offer training for therapists interested in learning how to provide MDMA-assisted psychotherapy, even though it is not currently available outside of clinical trials.
  • Compass Pathways began as a non-profit but more recently has transitioned into a for-profit organization investigating the use of psilocybin-assisted therapy for treatment-resistant depression. Recently Compass has stirred up controversy for attempting to patent the basic components of psychedelic-assisted therapy and seeking to create a monopoly in psychedelic medicine.
  • Usona Institute is a non-profit medical research organization dedicated to investigating the potential use of psilocybin and other psychedelics as adjuncts to psychotherapy in the treatment of mental health disorders. Recently, Usona Institute’s psilocybin program for depression made news when they  received breakthrough therapy designation by the FDA.

What are Psychedelics?

Psychedelics refer to various substances that produce distinctive altered states of consciousness. The effects of psychedelics include changes to thoughts, emotions, and perceptions, distorted sense of time, changes to sense of self, connectedness, sacredness, and an ineffable (i.e., indescribable) quality. Traditional or “classic” psychedelics are serotonergic agonists that include lysergic acid diethylamide (LSD), mescaline, dimethyltryptamine (DMT), psilocybin, and the psychedelic brew, Ayahuasca. Other substances with some similar effects are often grouped together with classic psychedelics, including 3,4-methylenedioxymethamphetamine (MDMA) and ketamine.


Portland Psychotherapy and Psychedelic-Assisted Therapy

At Portland Psychotherapy, we’ve been involved in psychedelic science in a variety of ways. Specifically, we’ve been

Conducting Research on Psychedelics and Psychedelic-Assisted Therapy

Providing Psychedelic Harm Reduction & Integration Services as We Wait for Legalization

Pulling Together Resources to Educate the Public About Psychedelics & Psychedelic-Assisted Therapy

What Makes Us Unique

Portland Psychotherapy is a clinic, research & training center with a unique business model that funds scientific research. This results in a team of therapists who are exceptionally well-trained and knowledgeable about their areas of specialty.